nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Transaminases increased—Lovastatin—atherosclerosis	0.0188	0.043	CcSEcCtD
Fenoldopam—Transaminases increased—Ezetimibe—atherosclerosis	0.0185	0.0422	CcSEcCtD
Fenoldopam—Transaminases increased—Simvastatin—atherosclerosis	0.0176	0.0402	CcSEcCtD
Fenoldopam—Transaminases increased—Pravastatin—atherosclerosis	0.0159	0.0364	CcSEcCtD
Fenoldopam—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00735	0.0168	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Niacin—atherosclerosis	0.00652	0.0149	CcSEcCtD
Fenoldopam—Urinary tract infection—Lovastatin—atherosclerosis	0.00623	0.0142	CcSEcCtD
Fenoldopam—Angina pectoris—Niacin—atherosclerosis	0.00601	0.0137	CcSEcCtD
Fenoldopam—Angina pectoris—Pravastatin—atherosclerosis	0.00592	0.0135	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00534	0.0122	CcSEcCtD
Fenoldopam—Flushing—Lovastatin—atherosclerosis	0.00534	0.0122	CcSEcCtD
Fenoldopam—Myocardial infarction—Pravastatin—atherosclerosis	0.00531	0.0121	CcSEcCtD
Fenoldopam—Sweating—Niacin—atherosclerosis	0.00528	0.012	CcSEcCtD
Fenoldopam—Urinary tract infection—Pravastatin—atherosclerosis	0.00527	0.012	CcSEcCtD
Fenoldopam—Flushing—Ezetimibe—atherosclerosis	0.00524	0.012	CcSEcCtD
Fenoldopam—Flushing—Simvastatin—atherosclerosis	0.005	0.0114	CcSEcCtD
Fenoldopam—Haemoglobin—Niacin—atherosclerosis	0.00497	0.0113	CcSEcCtD
Fenoldopam—Haemorrhage—Niacin—atherosclerosis	0.00494	0.0113	CcSEcCtD
Fenoldopam—Back pain—Lovastatin—atherosclerosis	0.00485	0.0111	CcSEcCtD
Fenoldopam—Muscle spasms—Lovastatin—atherosclerosis	0.00482	0.011	CcSEcCtD
Fenoldopam—Back pain—Ezetimibe—atherosclerosis	0.00475	0.0108	CcSEcCtD
Fenoldopam—Muscle spasms—Ezetimibe—atherosclerosis	0.00472	0.0108	CcSEcCtD
Fenoldopam—Flushing—Niacin—atherosclerosis	0.00459	0.0105	CcSEcCtD
Fenoldopam—Flushing—Pravastatin—atherosclerosis	0.00452	0.0103	CcSEcCtD
Fenoldopam—Muscle spasms—Simvastatin—atherosclerosis	0.0045	0.0103	CcSEcCtD
Fenoldopam—Insomnia—Rosuvastatin—atherosclerosis	0.00436	0.00996	CcSEcCtD
Fenoldopam—Palpitations—Ezetimibe—atherosclerosis	0.00434	0.00991	CcSEcCtD
Fenoldopam—Chest pain—Lovastatin—atherosclerosis	0.00426	0.00973	CcSEcCtD
Fenoldopam—Anxiety—Lovastatin—atherosclerosis	0.00425	0.0097	CcSEcCtD
Fenoldopam—Tension—Niacin—atherosclerosis	0.00422	0.00963	CcSEcCtD
Fenoldopam—Chest pain—Ezetimibe—atherosclerosis	0.00418	0.00955	CcSEcCtD
Fenoldopam—Nervousness—Niacin—atherosclerosis	0.00418	0.00954	CcSEcCtD
Fenoldopam—Tension—Pravastatin—atherosclerosis	0.00416	0.00949	CcSEcCtD
Fenoldopam—Muscle spasms—Niacin—atherosclerosis	0.00414	0.00944	CcSEcCtD
Fenoldopam—Constipation—Rosuvastatin—atherosclerosis	0.00413	0.00941	CcSEcCtD
Fenoldopam—Nervousness—Pravastatin—atherosclerosis	0.00411	0.00939	CcSEcCtD
Fenoldopam—Muscle spasms—Pravastatin—atherosclerosis	0.00407	0.00929	CcSEcCtD
Fenoldopam—Chest pain—Simvastatin—atherosclerosis	0.00399	0.0091	CcSEcCtD
Fenoldopam—Anxiety—Simvastatin—atherosclerosis	0.00398	0.00907	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00394	0.009	CcSEcCtD
Fenoldopam—Abdominal pain—Rosuvastatin—atherosclerosis	0.00381	0.0087	CcSEcCtD
Fenoldopam—Palpitations—Niacin—atherosclerosis	0.0038	0.00868	CcSEcCtD
Fenoldopam—Insomnia—Lovastatin—atherosclerosis	0.0037	0.00844	CcSEcCtD
Fenoldopam—Dyspnoea—Lovastatin—atherosclerosis	0.00364	0.00832	CcSEcCtD
Fenoldopam—Insomnia—Ezetimibe—atherosclerosis	0.00363	0.00828	CcSEcCtD
Fenoldopam—Chest pain—Pravastatin—atherosclerosis	0.00361	0.00823	CcSEcCtD
Fenoldopam—Anxiety—Pravastatin—atherosclerosis	0.00359	0.0082	CcSEcCtD
Fenoldopam—Dyspnoea—Ezetimibe—atherosclerosis	0.00357	0.00816	CcSEcCtD
Fenoldopam—Constipation—Lovastatin—atherosclerosis	0.0035	0.00798	CcSEcCtD
Fenoldopam—Insomnia—Simvastatin—atherosclerosis	0.00346	0.00789	CcSEcCtD
Fenoldopam—Constipation—Ezetimibe—atherosclerosis	0.00343	0.00783	CcSEcCtD
Fenoldopam—Tachycardia—Niacin—atherosclerosis	0.00343	0.00782	CcSEcCtD
Fenoldopam—Dyspnoea—Simvastatin—atherosclerosis	0.00341	0.00778	CcSEcCtD
Fenoldopam—Hyperhidrosis—Niacin—atherosclerosis	0.00339	0.00775	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00334	0.00763	CcSEcCtD
Fenoldopam—Hyperhidrosis—Pravastatin—atherosclerosis	0.00334	0.00763	CcSEcCtD
Fenoldopam—Diarrhoea—Rosuvastatin—atherosclerosis	0.0033	0.00753	CcSEcCtD
Fenoldopam—Hypotension—Niacin—atherosclerosis	0.00328	0.00749	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00328	0.00748	CcSEcCtD
Fenoldopam—Constipation—Simvastatin—atherosclerosis	0.00327	0.00746	CcSEcCtD
Fenoldopam—Body temperature increased—Lovastatin—atherosclerosis	0.00323	0.00738	CcSEcCtD
Fenoldopam—Abdominal pain—Lovastatin—atherosclerosis	0.00323	0.00738	CcSEcCtD
Fenoldopam—Dizziness—Rosuvastatin—atherosclerosis	0.00319	0.00728	CcSEcCtD
Fenoldopam—Insomnia—Niacin—atherosclerosis	0.00318	0.00725	CcSEcCtD
Fenoldopam—Body temperature increased—Ezetimibe—atherosclerosis	0.00317	0.00723	CcSEcCtD
Fenoldopam—Abdominal pain—Ezetimibe—atherosclerosis	0.00317	0.00723	CcSEcCtD
Fenoldopam—Dyspnoea—Niacin—atherosclerosis	0.00313	0.00714	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00313	0.00714	CcSEcCtD
Fenoldopam—Insomnia—Pravastatin—atherosclerosis	0.00313	0.00714	CcSEcCtD
Fenoldopam—Dyspnoea—Pravastatin—atherosclerosis	0.00308	0.00703	CcSEcCtD
Fenoldopam—Abdominal pain—Simvastatin—atherosclerosis	0.00302	0.0069	CcSEcCtD
Fenoldopam—Body temperature increased—Simvastatin—atherosclerosis	0.00302	0.0069	CcSEcCtD
Fenoldopam—Headache—Rosuvastatin—atherosclerosis	0.00302	0.0069	CcSEcCtD
Fenoldopam—Constipation—Pravastatin—atherosclerosis	0.00296	0.00675	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Niacin—atherosclerosis	0.00287	0.00655	CcSEcCtD
Fenoldopam—Nausea—Rosuvastatin—atherosclerosis	0.00287	0.00654	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00283	0.00645	CcSEcCtD
Fenoldopam—Diarrhoea—Lovastatin—atherosclerosis	0.0028	0.00638	CcSEcCtD
Fenoldopam—Abdominal pain—Niacin—atherosclerosis	0.00278	0.00633	CcSEcCtD
Fenoldopam—Body temperature increased—Niacin—atherosclerosis	0.00278	0.00633	CcSEcCtD
Fenoldopam—Diarrhoea—Ezetimibe—atherosclerosis	0.00274	0.00626	CcSEcCtD
Fenoldopam—Body temperature increased—Pravastatin—atherosclerosis	0.00273	0.00624	CcSEcCtD
Fenoldopam—Abdominal pain—Pravastatin—atherosclerosis	0.00273	0.00624	CcSEcCtD
Fenoldopam—Dizziness—Lovastatin—atherosclerosis	0.0027	0.00617	CcSEcCtD
Fenoldopam—Dizziness—Ezetimibe—atherosclerosis	0.00265	0.00605	CcSEcCtD
Fenoldopam—Diarrhoea—Simvastatin—atherosclerosis	0.00262	0.00597	CcSEcCtD
Fenoldopam—Vomiting—Lovastatin—atherosclerosis	0.0026	0.00593	CcSEcCtD
Fenoldopam—Headache—Lovastatin—atherosclerosis	0.00256	0.00584	CcSEcCtD
Fenoldopam—Vomiting—Ezetimibe—atherosclerosis	0.00255	0.00582	CcSEcCtD
Fenoldopam—Dizziness—Simvastatin—atherosclerosis	0.00253	0.00577	CcSEcCtD
Fenoldopam—Headache—Ezetimibe—atherosclerosis	0.00251	0.00573	CcSEcCtD
Fenoldopam—Vomiting—Simvastatin—atherosclerosis	0.00243	0.00555	CcSEcCtD
Fenoldopam—Nausea—Lovastatin—atherosclerosis	0.00243	0.00554	CcSEcCtD
Fenoldopam—Diarrhoea—Niacin—atherosclerosis	0.0024	0.00548	CcSEcCtD
Fenoldopam—Headache—Simvastatin—atherosclerosis	0.0024	0.00547	CcSEcCtD
Fenoldopam—Nausea—Ezetimibe—atherosclerosis	0.00238	0.00544	CcSEcCtD
Fenoldopam—Diarrhoea—Pravastatin—atherosclerosis	0.00237	0.0054	CcSEcCtD
Fenoldopam—Dizziness—Niacin—atherosclerosis	0.00232	0.0053	CcSEcCtD
Fenoldopam—Dizziness—Pravastatin—atherosclerosis	0.00229	0.00522	CcSEcCtD
Fenoldopam—Nausea—Simvastatin—atherosclerosis	0.00227	0.00518	CcSEcCtD
Fenoldopam—Vomiting—Niacin—atherosclerosis	0.00223	0.00509	CcSEcCtD
Fenoldopam—Headache—Niacin—atherosclerosis	0.0022	0.00502	CcSEcCtD
Fenoldopam—Vomiting—Pravastatin—atherosclerosis	0.0022	0.00502	CcSEcCtD
Fenoldopam—Headache—Pravastatin—atherosclerosis	0.00217	0.00494	CcSEcCtD
Fenoldopam—Nausea—Niacin—atherosclerosis	0.00209	0.00476	CcSEcCtD
Fenoldopam—Nausea—Pravastatin—atherosclerosis	0.00205	0.00469	CcSEcCtD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	5.72e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	5.7e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	5.67e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	5.66e-05	0.000101	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MAPK8—atherosclerosis	5.65e-05	0.000101	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AKT1—atherosclerosis	5.64e-05	0.0001	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKCG—atherosclerosis	5.63e-05	0.0001	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	5.61e-05	9.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	5.59e-05	9.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	5.59e-05	9.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—MTHFR—atherosclerosis	5.58e-05	9.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LPL—atherosclerosis	5.58e-05	9.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PPARG—atherosclerosis	5.57e-05	9.91e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	5.55e-05	9.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	5.5e-05	9.79e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—INS—atherosclerosis	5.49e-05	9.77e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SPP1—atherosclerosis	5.48e-05	9.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	5.48e-05	9.75e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARA—atherosclerosis	5.47e-05	9.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	5.46e-05	9.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—INS—atherosclerosis	5.46e-05	9.72e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	5.46e-05	9.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AGT—atherosclerosis	5.46e-05	9.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—AKT1—atherosclerosis	5.43e-05	9.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOB—atherosclerosis	5.43e-05	9.66e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	5.42e-05	9.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—INS—atherosclerosis	5.42e-05	9.64e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CCL2—atherosclerosis	5.4e-05	9.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—F2—atherosclerosis	5.4e-05	9.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	5.38e-05	9.57e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AGT—atherosclerosis	5.37e-05	9.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—LEP—atherosclerosis	5.35e-05	9.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APOE—atherosclerosis	5.35e-05	9.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	5.34e-05	9.5e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	5.33e-05	9.48e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IGF1—atherosclerosis	5.31e-05	9.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AGT—atherosclerosis	5.3e-05	9.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	5.3e-05	9.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	5.3e-05	9.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	5.29e-05	9.41e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	5.28e-05	9.4e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—LEP—atherosclerosis	5.26e-05	9.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APOE—atherosclerosis	5.26e-05	9.37e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	5.26e-05	9.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	5.24e-05	9.32e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VEGFA—atherosclerosis	5.22e-05	9.29e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	5.21e-05	9.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	5.2e-05	9.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—APOE—atherosclerosis	5.19e-05	9.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LPL—atherosclerosis	5.18e-05	9.22e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—STAT3—atherosclerosis	5.17e-05	9.2e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	5.17e-05	9.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CAV1—atherosclerosis	5.15e-05	9.16e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—APOA1—atherosclerosis	5.13e-05	9.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	5.1e-05	9.09e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PDGFB—atherosclerosis	5.07e-05	9.03e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	5.04e-05	8.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—F2—atherosclerosis	5.04e-05	8.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	5.04e-05	8.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	5.02e-05	8.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ALB—atherosclerosis	5.01e-05	8.91e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	4.97e-05	8.85e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—F2—atherosclerosis	4.96e-05	8.83e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AGT—atherosclerosis	4.95e-05	8.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	4.95e-05	8.81e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MAPK3—atherosclerosis	4.94e-05	8.79e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	4.91e-05	8.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—INS—atherosclerosis	4.89e-05	8.7e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	4.89e-05	8.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	4.89e-05	8.7e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—LEP—atherosclerosis	4.85e-05	8.63e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOE—atherosclerosis	4.85e-05	8.63e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	4.83e-05	8.59e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NOS3—atherosclerosis	4.81e-05	8.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	4.81e-05	8.56e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CAV1—atherosclerosis	4.81e-05	8.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APOA1—atherosclerosis	4.8e-05	8.54e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TGFB1—atherosclerosis	4.79e-05	8.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—NOS3—atherosclerosis	4.79e-05	8.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AGT—atherosclerosis	4.77e-05	8.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	4.75e-05	8.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	4.75e-05	8.45e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	4.73e-05	8.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CG—atherosclerosis	4.69e-05	8.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—LEP—atherosclerosis	4.67e-05	8.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOE—atherosclerosis	4.67e-05	8.32e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ESR1—atherosclerosis	4.63e-05	8.24e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	4.63e-05	8.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	4.62e-05	8.22e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	4.62e-05	8.22e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—F2—atherosclerosis	4.57e-05	8.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—INS—atherosclerosis	4.57e-05	8.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	4.55e-05	8.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	4.54e-05	8.08e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—atherosclerosis	4.52e-05	8.05e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—INS—atherosclerosis	4.5e-05	8e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	4.49e-05	8e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	4.49e-05	7.99e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	4.46e-05	7.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—INS—atherosclerosis	4.44e-05	7.9e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AGT—atherosclerosis	4.43e-05	7.89e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	4.42e-05	7.87e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	4.42e-05	7.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—atherosclerosis	4.41e-05	7.85e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—F2—atherosclerosis	4.41e-05	7.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—atherosclerosis	4.38e-05	7.8e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	4.38e-05	7.79e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	4.35e-05	7.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOE—atherosclerosis	4.34e-05	7.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—LEP—atherosclerosis	4.34e-05	7.73e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	4.3e-05	7.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	4.29e-05	7.64e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	4.29e-05	7.63e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCL8—atherosclerosis	4.27e-05	7.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	4.22e-05	7.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	4.21e-05	7.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	4.2e-05	7.47e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	4.19e-05	7.46e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	4.15e-05	7.38e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—INS—atherosclerosis	4.14e-05	7.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	4.13e-05	7.35e-05	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	4.12e-05	7.34e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—F2—atherosclerosis	4.1e-05	7.29e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CCL2—atherosclerosis	4.08e-05	7.26e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	4.07e-05	7.24e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ALB—atherosclerosis	4.07e-05	7.24e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—IL6—atherosclerosis	4.06e-05	7.23e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	4.04e-05	7.19e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1—atherosclerosis	4.01e-05	7.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	4.01e-05	7.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	4.01e-05	7.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—INS—atherosclerosis	3.99e-05	7.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	3.94e-05	7.02e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	3.93e-05	6.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	3.92e-05	6.98e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NOS3—atherosclerosis	3.89e-05	6.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	3.86e-05	6.87e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—atherosclerosis	3.86e-05	6.87e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NFKB1—atherosclerosis	3.82e-05	6.8e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	3.81e-05	6.78e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	3.81e-05	6.78e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	3.8e-05	6.77e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	3.77e-05	6.71e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK8—atherosclerosis	3.76e-05	6.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	3.75e-05	6.68e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—atherosclerosis	3.75e-05	6.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—INS—atherosclerosis	3.71e-05	6.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	3.71e-05	6.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	3.7e-05	6.58e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	3.67e-05	6.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	3.67e-05	6.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	3.65e-05	6.5e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOS3—atherosclerosis	3.63e-05	6.47e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	3.62e-05	6.44e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IL6—atherosclerosis	3.61e-05	6.43e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	3.59e-05	6.39e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—atherosclerosis	3.56e-05	6.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	3.55e-05	6.32e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	3.5e-05	6.23e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	3.5e-05	6.22e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—atherosclerosis	3.47e-05	6.17e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	3.44e-05	6.12e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—atherosclerosis	3.43e-05	6.11e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	3.43e-05	6.11e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	3.42e-05	6.09e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	3.41e-05	6.07e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	3.4e-05	6.06e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	3.39e-05	6.03e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	3.38e-05	6.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	3.38e-05	6.01e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	3.35e-05	5.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	3.34e-05	5.94e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—atherosclerosis	3.33e-05	5.93e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	3.33e-05	5.92e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MAPK3—atherosclerosis	3.28e-05	5.84e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	3.25e-05	5.79e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	3.24e-05	5.76e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—atherosclerosis	3.22e-05	5.74e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	3.21e-05	5.72e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TGFB1—atherosclerosis	3.18e-05	5.67e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	3.18e-05	5.66e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	3.16e-05	5.63e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	3.14e-05	5.59e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	3.13e-05	5.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	3.13e-05	5.56e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	3.12e-05	5.55e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	3.11e-05	5.54e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	3.11e-05	5.53e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	3.09e-05	5.5e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	3.08e-05	5.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	3.07e-05	5.46e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—IL6—atherosclerosis	3.07e-05	5.46e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	3.06e-05	5.44e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	3e-05	5.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	2.95e-05	5.26e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	2.92e-05	5.2e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—atherosclerosis	2.92e-05	5.19e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	2.89e-05	5.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	2.89e-05	5.14e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NFKB1—atherosclerosis	2.88e-05	5.13e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	2.86e-05	5.09e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	2.84e-05	5.05e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK8—atherosclerosis	2.84e-05	5.05e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	2.84e-05	5.05e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—atherosclerosis	2.83e-05	5.03e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	2.81e-05	5.01e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	2.81e-05	5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	2.79e-05	4.96e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	2.78e-05	4.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	2.74e-05	4.88e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	2.73e-05	4.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	2.73e-05	4.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	2.72e-05	4.85e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	2.69e-05	4.78e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	2.65e-05	4.71e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.62e-05	4.66e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2.61e-05	4.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	2.61e-05	4.64e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.59e-05	4.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	2.58e-05	4.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	2.54e-05	4.52e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	2.53e-05	4.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	2.52e-05	4.49e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	2.5e-05	4.45e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.48e-05	4.41e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.4e-05	4.28e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL6—atherosclerosis	2.4e-05	4.27e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	2.39e-05	4.25e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL6—atherosclerosis	2.37e-05	4.21e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	2.34e-05	4.17e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	2.32e-05	4.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	2.32e-05	4.12e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.22e-05	3.95e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—atherosclerosis	2.21e-05	3.94e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—atherosclerosis	2.2e-05	3.92e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	2.18e-05	3.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.15e-05	3.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL6—atherosclerosis	2.14e-05	3.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL6—atherosclerosis	2e-05	3.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	1.97e-05	3.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL6—atherosclerosis	1.96e-05	3.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	1.84e-05	3.28e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	1.81e-05	3.23e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL6—atherosclerosis	1.81e-05	3.22e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—atherosclerosis	1.79e-05	3.18e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.74e-05	3.11e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.67e-05	2.97e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.62e-05	2.89e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	1.61e-05	2.86e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.5e-05	2.66e-05	CbGpPWpGaD
